LYUMJEV Junior KwikPen 100 [iU]/mL
Insulin lispro-aabc · INJECTION, SOLUTION · Eli Lilly and Company
No Recall HistoryCurrently in Shortage
Plain English
LYUMJEV Junior KwikPen is a injection, solution containing insulin lispro-aabc at 100 [iU]/mL, taken subcutaneous. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- LYUMJEV Junior KwikPen
- Generic Name
- Insulin lispro-aabc
- NDC Code (Product)
0002-8351- Manufacturer
- Eli Lilly and Company
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761109
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 06/15/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is LYUMJEV Junior KwikPen used for?
LYUMJEV Junior KwikPen contains Insulin lispro-aabc. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is LYUMJEV Junior KwikPen a controlled substance?
LYUMJEV Junior KwikPen is not classified as a controlled substance by the DEA.
What is the generic name for LYUMJEV Junior KwikPen?
The generic name for LYUMJEV Junior KwikPen is Insulin lispro-aabc. There are 6 other brand versions of Insulin lispro-aabc.
What is the NDC code for LYUMJEV Junior KwikPen 100 [iU]/mL?
The NDC (National Drug Code) for LYUMJEV Junior KwikPen 100 [iU]/mL is 0002-8351, listed by Eli Lilly and Company.